Skip to main content
. 2018 Mar-Apr;93(2):197–204. doi: 10.1590/abd1806-4841.20186069

Table 4.

Health outcomes in those diagnosed with mild, moderate, or severe psoriasis (Mean ± SD)

  Psoriasis severity
  Total (N=210) Mild (N=157) Moderate (N=42) Severe (N=11)
SF-12v2: MCS 42.92 ± 10.97 43.23 ± 11.22 42.45 ± 10.54 40.23 ± 9.26
SF-12v2: PCS 51.41 ± 7.52 51.91 ± 6.86 51.15 ± 7.99 45.23 ± 11.78
Health state utility score 0.654 ± 0.107 0.658 ± 0.104 0.653 ± 0.118 0.587 ± 0.076
Absenteeism% 8.24 ± 19.27 9.38 ± 21.66 5.15 ± 10.01 4.75 ± 6.60
Presenteeism % 25.03 ± 27.01 23.68 ± 26.52 25.88 ± 27.76 48.00 ± 26.83
Overall work impairment % 28.80 ± 29.82 28.53 ± 30.64 28.32 ± 28.70 39.75 ± 17.63
Activityimpairment% 28.95 ± 29.23 27.52 ± 27.61 32.62 ± 33.86 35.45 ± 33.57
Physician visits in the past 6 months 6.69 ± 7.31 6.51 ± 6.76 7.40 ± 9.52 6.55 ± 5.47
Emergency room visits in the past 6 months 0.79 ± 1.89 0.82 ± 2.05 0.74 ± 1.25 0.64 ± 1.50
Hospitalizations in the past 6 months 0.25 ± 0.83 0.20 ± 0.70 0.43 ± 1.27 0.18 ± 0.40